Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Challenging Conventional Diagnostic Methods By Comprehensive Molecular Diagnostics: Results of a Nationwide Prospective Comparison in Children with Acute Lymphoblastic Leukemia

Judith M. Boer, Marco J. Koudijs, Lennart A. Kester, Edwin Sonneveld, Jayne Y. Hehir-Kwa, Simone Snijder, Esmé Waanders, Arjan Buijs, Valerie de Haas, Inge M. van der Sluis, Rob Pieters, Monique L. den Boer, Bastiaan B.J. Tops

Blood (2024) 144 (Supplement 1): 1459.

https://doi.org/10.1182/blood-2024-193387

Published: 2024

Journal Articles

High Clinical Benefit of Diagnostic RNA Sequencing in Pediatric T-Cell Lymphoblastic Lymphoma for the Identification of Potentially Targetable Risk Groups

Emma Kroeze, Michelle M Kleisman, Lennart A. Kester, Edwin Sonneveld, Marco J. Koudijs, Uri Ilan, Auke Beishuizen, Melanie M Hagleitner, Roland P. Kuiper, Jan LC Loeffen

Blood (2024) 144 (Supplement 1): 2985.

https://doi.org/10.1182/blood-2024-210414

Published: 2024

Journal Articles

ABL-Class Fusion Gene Induced Pediatric CML Presenting As ALL

Peter M. Hoogerbrugge, Maaike Luesink, Judith M. Boer, Inge Van Outersterp, Edwin Sonneveld, Anja De Jong, Stefan Nierkens, Vincent H.J. Van Der Velden, Arjan Buijs, Monique L. den Boer

Blood (2024) 144 (Supplement 1): 5851.

https://doi.org/10.1182/blood-2024-203064

Published: 2024

Journal Articles

Secondary Lesions and Sensitivity to Signaling Inhibitors of Pediatric iAMP21 B-Cell Precursor Acute Lymphoblastic Leukemia

Anna Ostergaard, Femke M. Hormann, Stijn Van Den Broek, Aurelie Boeree, Cesca Van De Ven, Gabriele Escherich, Edwin Sonneveld, Judith M. Boer, Monique L. Den Boer

Blood (2023) 142 (Supplement 1): 1613.

https://doi.org/10.1182/blood-2023-179719

Published: 2023

Journal Articles

Nucleophosmin (NPM1) Type D Genotype Is Associated with Distinct Outcome in Acute Myeloid Leukemia - an AIEOP-BFM and COG-SWOG Intergroup Collaboration

Martina Pigazzi, Claudia Tregnago, Rhonda E Ries, Maddalena Benetton, Todd A. Alonzo, Nicolas Duployez, Edwin Sonneveld, Jonas Abrahamsson, Linda Fogelstrand, Nils Von Neuhoff, Henrik Hasle, Dirk Reinhardt, Franco Locatelli, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 840.

https://doi.org/10.1182/blood-2023-181872

Published: 2023

Journal Articles

A Novel Germline PAX5 Single Exon Deletion in a Paediatric Patient with B-Cell Leukaemia

Nienke van Engelen, Merel A. Roest, Freerk van Dijk, Edwin Sonneveld, Reno Bladergroen, Simon van Reijmersdal, Vincent H.J. van der Velden, Patricia G. Hoogeveen, W.A. Kors, Esme Waanders, Roland P. Kuiper, Marjolijn C.J. Jongmans

Blood (2022) 140 (Supplement 1): 3181.

https://doi.org/10.1182/blood-2022-159959

Published: 2022

Journal Articles

Mutational Mechanisms in Pediatric Acute Lymphoblastic Leukemia with Multiple Relapses

Cédric G van der Ham, Stefan H Lelieveld, Željko Antic, Marley Yeong, Lianne C Suurenbroek, Dorette S van Ingen Schenau, Lennart A. Kester, Liset Westera, Edwin Sonneveld, Peter M. Hoogerbrugge, Vincent H.J. van der Velden, Frank N van Leeuwen, Roland P. Kuiper

Blood (2022) 140 (Supplement 1): 3463–3464.

https://doi.org/10.1182/blood-2022-159410

Published: 2022

Journal Articles

From Generic RNA-Based MRD Assessment Towards Patient-Specific Genomic (DNA-based) MRD in AML and Other Non-B Cell Acute Leukemia

Edwin Sonneveld, Lennart Kester, Liset Westera, Janneke Blom, Marco J. Koudijs, Eric Strengman, Marc van Tuil, Maaike Luesink, Bianca F. Goemans, Bastiaan Tops

Blood (2022) 140 (Supplement 1): 11817–11818.

https://doi.org/10.1182/blood-2022-162311

Published: 2022

Journal Articles

Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders

Rob Pieters, Hester A. De Groot-Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta Fiocco, Vincent H.J. van der Velden, Berna Beverloo, Marc Bierings, Valerie De Haas, Peter M. Hoogerbrugge, Inge M. Van Der Sluis, Wim J.E. Tissing, Margreet Veening, Judith M. Boer, Monique L. den Boer

Blood (2022) 140 (Supplement 1): 519–520.

https://doi.org/10.1182/blood-2022-165931

Published: 2022

Journal Articles

RNA-Sequencing Improves Diagnostics and Treatment of Pediatric Hematological Malignancies

Marco J. Koudijs, Lennart A. Kester, Jayne Y. Hehir-Kwa, Eugene T.P. Verwiel, Erik Strengman, Marc van Tuil, Douwe van der Leest, Edwin Sonneveld, Patrick Kemmeren, Valerie De Haas, Josef Vormoor, Bas B.J. Tops

Blood (2021) 138 (Supplement 1): 107.

https://doi.org/10.1182/blood-2021-147692

Published: 2021

Journal Articles

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Anne-Sofie Skou, Kristian Løvvik Juul-Dam, Erik Delsing Malmberg, Anna Rehammar, Anastasia Soboli, Azadeh Anbarlou, Erik Kristiansson, Jonas Abrahamsson, Bernward Zeller, Kirsi Jahnukainen, Edwin Sonneveld, Birgitte Lausen, Anni Aggerholm, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2021) 138 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2021-153411

Published: 2021

Journal Articles

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

Blood (2018) 132 (15): 1584–1592.

https://doi.org/10.1182/blood-2018-05-849059

Published: 2018

Includes: Supplemental data

Journal Articles

RNA-based FLT3 -ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

Blood (2018) 131 (22): 2485–2489.

https://doi.org/10.1182/blood-2017-12-819508

Published: 2018

Includes: Supplemental data

Journal Articles

A Dynamic Epigenetic Landscape in Genetic and Immunophenotypic Stable Pediatric AML

Diana Hanekamp, MSc, Jennifer R. Scheick, Yaseswini Neelamraju, Edwin Sonneveld, PhD, Valerie de Haas, MD PhD, Gert J. Ossenkoppele, MD PhD, Gerrit J. Schuurhuis, PhD, Gertjan J.L. Kaspers, MD PhD, Francine E. Garrett-Bakelman, MDPhD, Jacqueline Cloos, PhD

Blood (2017) 130 (Supplement 1): 2686.

https://doi.org/10.1182/blood.V130.Suppl_1.2686.2686

Published: 2017

Journal Articles

NUP98-KDM5A Fusion Gene Is Not Exclusive to Acute Megakaryoblastic Leukemia and Is an Independent Predictor of Poor Prognosis

Sanne Noort, MD MSc, Robert B Gerbing, Todd A Alonzo, PhD, Jenny L. Smith, MSc, MD, Edwin Sonneveld, PhD, Franco Locatelli, MD PhD, Dirk Reinhardt, MD, Andre Baruchel, MD, Jan Stary, Marry M. Van den Heuvel-Eibrink, MD, C. Michel Zwaan, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 3934.

https://doi.org/10.1182/blood.V130.Suppl_1.3934.3934

Published: 2017

Journal Articles

Distinct Outcome Based on Fusion Transcript in t(16;21) Rearranged Pediatric AML, a Collaborative Retrospective Analysis By the I-BFM SG

Blood (2017) 130 (Supplement 1): 184.

https://doi.org/10.1182/blood.V130.Suppl_1.184.184

Published: 2017

Journal Articles

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

Blood (2017) 129 (3): 347–357.

https://doi.org/10.1182/blood-2016-07-726307

Published: 2017

Includes: Supplemental data

Journal Articles

Genomic Architecture and Clonal Dynamics of Early Relapsed BCP-ALL

Zeljko Antic, MD, Jiangyan Yu, MSc, Simon V. van Reijmersdal, Renske Kuiper, Edwin Sonneveld, PhD, Frank N. van Leeuwen, PhD, Peter M. Hoogerbrugge, MD PhD, Esmé Waanders, PhD, Roland P. Kuiper, PhD

Blood (2016) 128 (22): 4072.

https://doi.org/10.1182/blood.V128.22.4072.4072

Published: 2016

Journal Articles

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Blood (2016) 128 (7): 911–922.

https://doi.org/10.1182/blood-2016-03-704973

Published: 2016

Includes: Supplemental data

Journal Articles

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

Jasmijn D. E. de Rooij, Riccardo Masetti, Marry M. van den Heuvel-Eibrink, Jean-Michel Cayuela, Jan Trka, Dirk Reinhardt, Mareike Rasche, Edwin Sonneveld, Todd A. Alonzo, Maarten Fornerod, Martin Zimmermann, Martina Pigazzi, Rob Pieters, Soheil Meshinchi, C. Michel Zwaan, Franco Locatelli

Blood (2016) 127 (26): 3424–3430.

https://doi.org/10.1182/blood-2016-01-695551

Published: 2016

Includes: Supplemental data

NARROW

Challenging Conventional Diagnostic Methods By Comprehensive Molecular Diagnostics: Results of a Nationwide Prospective Comparison in Children with Acute Lymphoblastic Leukemia

High Clinical Benefit of Diagnostic RNA Sequencing in Pediatric T-Cell Lymphoblastic Lymphoma for the Identification of Potentially Targetable Risk Groups

ABL-Class Fusion Gene Induced Pediatric CML Presenting As ALL

Secondary Lesions and Sensitivity to Signaling Inhibitors of Pediatric iAMP21 B-Cell Precursor Acute Lymphoblastic Leukemia

Nucleophosmin (NPM1) Type D Genotype Is Associated with Distinct Outcome in Acute Myeloid Leukemia - an AIEOP-BFM and COG-SWOG Intergroup Collaboration

A Novel Germline PAX5 Single Exon Deletion in a Paediatric Patient with B-Cell Leukaemia

Mutational Mechanisms in Pediatric Acute Lymphoblastic Leukemia with Multiple Relapses

From Generic RNA-Based MRD Assessment Towards Patient-Specific Genomic (DNA-based) MRD in AML and Other Non-B Cell Acute Leukemia

Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders

RNA-Sequencing Improves Diagnostics and Treatment of Pediatric Hematological Malignancies

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

RNA-based FLT3 -ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

A Dynamic Epigenetic Landscape in Genetic and Immunophenotypic Stable Pediatric AML

NUP98-KDM5A Fusion Gene Is Not Exclusive to Acute Megakaryoblastic Leukemia and Is an Independent Predictor of Poor Prognosis

Distinct Outcome Based on Fusion Transcript in t(16;21) Rearranged Pediatric AML, a Collaborative Retrospective Analysis By the I-BFM SG

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

Genomic Architecture and Clonal Dynamics of Early Relapsed BCP-ALL

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only